SEC Filing Analysis: Celularity Inc (CELU)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director was awarded 19,231 Restricted Stock Units (RSUs) as compensation, which vested immediately.
• Market Impact: Neutral, as this is a routine, non-cash compensation event and not an open-market trade.

Company Information

Field	Value
Company	Celularity Inc
Ticker Symbol	CELU
CIK	0001752828
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Ling Geoffrey M.D.
CIK	0001800097
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4/A
Transaction Date	2026-01-12
Transaction Code	A (Award)
Security Type	Class A Common Stock
Shares Involved	19,231
Price Per Share	$0.00
Total Value	$0
Shares Owned After	256,026
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	19,231
% of Shares Outstanding	Not Available
Post-Transaction Ownership	256,026 shares (N/A % of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a total value of $0, making it financially immaterial against the company's $40 million market capitalization.
• Dilution Impact: The issuance of 19,231 shares as RSUs causes minor shareholder dilution. The exact percentage impact cannot be calculated as the number of shares outstanding is not available.
• Transaction Significance: The transaction's significance is low. It represents director compensation, not a market-based investment decision, and carries no monetary value at the time of the grant.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Stock grants are a common form of compensation and are not typically interpreted by the market as a signal of insider sentiment regarding the company's future performance.

Volume & Sentiment

• Expected Volume Impact: Negligible. This is not an open-market transaction and will not directly impact trading volume.
• Sentiment Indicator: Neutral. The filing is informational regarding executive compensation.

Additional Context

Transaction Notes

• Special Circumstances: The filing footnote clarifies these are Restricted Stock Units (RSUs) granted under the company's equity incentive plan, which vested immediately upon grant.